Creating a new approach to manage aspirin use in older adults after emergency visits.
Official title: Developing a foundation for a novel emergency department-based intervention to address inappropriate aspirin
Funded at Univ of North Carolina Chapel Hill · NIH-10977249 · Data updated 2026-11-12
This study is looking at how well older adults who have had a bleeding issue in the emergency room are informed about whether they should keep taking aspirin or stop, so we can improve the way doctors and patients talk about this important decision.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | September 17, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $310,120 |
| NIH project number | 1R03AG089044-01 |
| Project ID | NIH-10977249 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults who have been treated in the emergency department for bleeding events and are currently using aspirin.
✕Less likely to help
Patients who do not use aspirin or who are not older adults may not benefit from this research.
What this research studies
This research focuses on understanding how older adults who have experienced a bleeding event in the emergency department are counseled about their aspirin use. It aims to identify how often these patients receive information about the risks and benefits of continuing or stopping aspirin therapy after such events. By using Intervention Mapping Theory, the study will gather data on patient and provider interactions to develop a new intervention that ensures better communication and decision-making regarding aspirin use in this vulnerable population.
Why it matters
Potential benefit: If successful, this research could lead to improved safety and health outcomes for older adults by reducing inappropriate aspirin use and its associated risks.
How similar studies have gone: While there is ongoing research into deprescribing practices, this specific approach targeting aspirin use in older adults post-ED visit is relatively novel.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Casey, Martin Francis — Univ of North Carolina Chapel Hill
- Study coordinator: Casey, Martin Francis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.